Federal award (DEFINITIVE CONTRACT, fiscal year 2023)
Recipient: SUNFIRE BIOTECHNOLOGIES LLC
Awarding agency: Department of Defense / Defense Health Agency
Funding agency: Department of Defense / Department of the Army
Period of performance: 2022-02-14 to 2024-06-13
Current total value of award: $1052346.25
Description: DHA SBIR PHASE II PROPOSAL TITLED: TRANSITIONING THE MULTIPLEXED BACTERICIDAL ASSAY FOR SHIGELLA LIPOPOLYSACCHARIDE ANTIBODIES FOR COMMERCIAL USE